These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
152 related articles for article (PubMed ID: 27588406)
1. Gata3 restrains B cell proliferation and cooperates with p18INK4c to repress B cell lymphomagenesis. Liu S; Chan HL; Bai F; Ma J; Scott A; Robbins DJ; Capobianco AJ; Zhu P; Pei XH Oncotarget; 2016 Sep; 7(39):64007-64020. PubMed ID: 27588406 [TBL] [Abstract][Full Text] [Related]
2. Loss of function of GATA3 induces basal-like mammary tumors. Bai F; Zheng C; Liu X; Chan HL; Liu S; Ma J; Ren S; Zhu WG; Pei XH Theranostics; 2022; 12(2):720-733. PubMed ID: 34976209 [No Abstract] [Full Text] [Related]
3. Expression of p16Ink4a compensates for p18Ink4c loss in cyclin-dependent kinase 4/6-dependent tumors and tissues. Ramsey MR; Krishnamurthy J; Pei XH; Torrice C; Lin W; Carrasco DR; Ligon KL; Xiong Y; Sharpless NE Cancer Res; 2007 May; 67(10):4732-41. PubMed ID: 17510401 [TBL] [Abstract][Full Text] [Related]
4. CDK inhibitor p18(INK4c) is a downstream target of GATA3 and restrains mammary luminal progenitor cell proliferation and tumorigenesis. Pei XH; Bai F; Smith MD; Usary J; Fan C; Pai SY; Ho IC; Perou CM; Xiong Y Cancer Cell; 2009 May; 15(5):389-401. PubMed ID: 19411068 [TBL] [Abstract][Full Text] [Related]
5. RNA interference reveals a requirement for both p18INK4c and p27Kip1 in B lymphopoiesis. Wang YY; Li Z; Jiao D; Zhang Z; Shao X; Yuan J; Yu P J Mol Cell Biol; 2010 Aug; 2(4):209-16. PubMed ID: 20671115 [TBL] [Abstract][Full Text] [Related]
6. Cooperation of Gata3, c-Myc and Notch in malignant transformation of double positive thymocytes. van Hamburg JP; de Bruijn MJ; Dingjan GM; Beverloo HB; Diepstraten H; Ling KW; Hendriks RW Mol Immunol; 2008 Jun; 45(11):3085-95. PubMed ID: 18471881 [TBL] [Abstract][Full Text] [Related]
7. Thpok-independent repression of Runx3 by Gata3 during CD4+ T-cell differentiation in the thymus. Xiong Y; Castro E; Yagi R; Zhu J; Lesourne R; Love PE; Feigenbaum L; Bosselut R Eur J Immunol; 2013 Apr; 43(4):918-28. PubMed ID: 23310955 [TBL] [Abstract][Full Text] [Related]
8. Fidelity and infidelity in commitment to B-lymphocyte lineage development. Rolink AG; Schaniel C; Busslinger M; Nutt SL; Melchers F Immunol Rev; 2000 Jun; 175():104-11. PubMed ID: 10933595 [TBL] [Abstract][Full Text] [Related]
9. Genetic evidence for functional dependency of p18Ink4c on Cdk4. Pei XH; Bai F; Tsutsui T; Kiyokawa H; Xiong Y Mol Cell Biol; 2004 Aug; 24(15):6653-64. PubMed ID: 15254233 [TBL] [Abstract][Full Text] [Related]
10. Regulation of T cell differentiation and alloimmunity by the cyclin-dependent kinase inhibitor p18ink4c. Rowell EA; Wang L; Chunder N; Hancock WW; Wells AD PLoS One; 2014; 9(3):e91587. PubMed ID: 24614758 [TBL] [Abstract][Full Text] [Related]
12. Gene expression profiling in mice with enforced Gata3 expression reveals putative targets of Gata3 in double positive thymocytes. van Hamburg JP; de Bruijn MJ; Ribeiro de Almeida C; Dingjan GM; Hendriks RW Mol Immunol; 2009 Oct; 46(16):3251-60. PubMed ID: 19729201 [TBL] [Abstract][Full Text] [Related]
13. Transcriptional repression of Gata3 is essential for early B cell commitment. Banerjee A; Northrup D; Boukarabila H; Jacobsen SE; Allman D Immunity; 2013 May; 38(5):930-42. PubMed ID: 23684985 [TBL] [Abstract][Full Text] [Related]
14. Gata3/Ruvbl2 complex regulates T helper 2 cell proliferation via repression of Cdkn2c expression. Hosokawa H; Tanaka T; Kato M; Shinoda K; Tohyama H; Hanazawa A; Tamaki Y; Hirahara K; Yagi R; Sakikawa I; Morita A; Nagira M; Poyurovsky MV; Suzuki Y; Motohashi S; Nakayama T Proc Natl Acad Sci U S A; 2013 Nov; 110(46):18626-31. PubMed ID: 24167278 [TBL] [Abstract][Full Text] [Related]
15. Reduced expression of cell cycle regulator p18(INK4C) in human hepatocellular carcinoma. Morishita A; Masaki T; Yoshiji H; Nakai S; Ogi T; Miyauchi Y; Yoshida S; Funaki T; Uchida N; Kita Y; Funakoshi F; Usuki H; Okada S; Izuishi K; Watanabe S; Kurokohchi K; Kuriyama S Hepatology; 2004 Sep; 40(3):677-86. PubMed ID: 15349907 [TBL] [Abstract][Full Text] [Related]
16. A novel orally active small molecule potently induces G1 arrest in primary myeloma cells and prevents tumor growth by specific inhibition of cyclin-dependent kinase 4/6. Baughn LB; Di Liberto M; Wu K; Toogood PL; Louie T; Gottschalk R; Niesvizky R; Cho H; Ely S; Moore MA; Chen-Kiang S Cancer Res; 2006 Aug; 66(15):7661-7. PubMed ID: 16885367 [TBL] [Abstract][Full Text] [Related]
17. Noxa mediates p18INK4c cell-cycle control of homeostasis in B cells and plasma cell precursors. Bretz J; Garcia J; Huang X; Kang L; Zhang Y; Toellner KM; Chen-Kiang S Blood; 2011 Feb; 117(7):2179-88. PubMed ID: 21163929 [TBL] [Abstract][Full Text] [Related]
18. Fbw7 targets GATA3 through cyclin-dependent kinase 2-dependent proteolysis and contributes to regulation of T-cell development. Kitagawa K; Shibata K; Matsumoto A; Matsumoto M; Ohhata T; Nakayama KI; Niida H; Kitagawa M Mol Cell Biol; 2014 Jul; 34(14):2732-44. PubMed ID: 24820417 [TBL] [Abstract][Full Text] [Related]
19. Identification of functional elements of p18INK4C essential for binding and inhibition of cyclin-dependent kinase (CDK) 4 and CDK6. Noh SJ; Li Y; Xiong Y; Guan KL Cancer Res; 1999 Feb; 59(3):558-64. PubMed ID: 9973200 [TBL] [Abstract][Full Text] [Related]
20. c-Myb regulates lineage choice in developing thymocytes via its target gene Gata3. Maurice D; Hooper J; Lang G; Weston K EMBO J; 2007 Aug; 26(15):3629-40. PubMed ID: 17641686 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]